N-terminal pro-brain natriuretic peptide level as a screening tool for cardiac involvement in paediatric diseases of extracardiac origin

Daniels LB, Maisel AS (2007) Natriuretic Peptides. J Am Coll Cardiol 50:2357–2368 Levin ER, Gardner DG, Samson WK (1998) Natriuretic peptides. N Engl J Med 339(5):321–328 Cortes R, Otero MR, Morillas P, Rosello-Lleti E, Grigorian L, Marinez-Dolz L, de Burgos FG, Calabuig JR, Soria F, Lozano T, Portoles M, Bertomeu V (2008) Obese and nonobese patients with essential hypertension show similar N-terminal proBNP plasma levels. Am J Hypertens 21:820–825 Hammerer-Lercher A, Mair J, Tews G, Puschendorf B, Sommer R (2005) N-terminal pro-B-type natriuretic peptide concentrations are markedly higher in the umbilical cord blood of newborns than in their mothers. Clin Chem 51(5):913–915 Bar-Oz B, Lev-Sagie A, Arad I, Salpeter L, Nir A (2005) N-terminal pro-B-type natriuretic peptide concentrations in mothers just before delivery, in cord blood and in newborns. Clin Chem 51(5):26–927 Lin NC, Landt ML, Trinkhaus KM, Balzer DT, Kort HW, Canter CE (2005) Relation of age, severity of illness, and hemodynamics with brain natriuretic peptide levels in patients <20 years of age with heart disease. Am J Cardiol 96(6):847–850 Norozi K, Binder L, Brack C, Pottho L, Hess G, Wessel A (2008) Intravenous luteinizing hormone-releasing hormone has no effect on serum N-terminal pro-brain natriuretic peptide in children and adolescents. Pediatr Int 50:1–6 Bruch C, Fischer C, Sindermann J, Stypmann J, Breithardt G, Gradaus R (2008) Comparison of the prognostic usefulness of N-terminal pro-brain-natriuretic peptide in patients with heart failure with versus without chronic kidney disease. Am J Cardiol 102:469–474 Das SR, Abdulla SM, Leonard D, Drazner MH, Khera A, McGuire DK, de Lemos JA (2008) Association between renal function and circulating levels of natriuretic peptides (from the Dallas heart study). Am J Cardiol 102:1394–1398 Kato K, Murakami H, Isozaki O, Tsushima T, Takomo K (2008) Serum concentrations of BNP and ANP in patients with Thyrotoxicosis. Endocr J (Epub ahead of print) Ozmen B, Ozmen D, Parildar Z, Mutaf I, Bayindir O (2007) Serum N-terminal-pro-B-type natriuretic peptide (NT-pro-BNP) levels in hyperthyroidism and hypothyroidism. Endocr Res 32(1–2):1–8 Henrikson JH, Gotze JP, Fuglsang S, Christensen E, Bendtsen F, Moller S (2003) Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease. Gut 52(10):1511–1517 Fried I, Bar-Oz B, Algur N, Fried E, Gavri S, Yatsiv I, Perles Z, Rein AJ, Bass R, Nir A (2006) Comparison of N-terminal pro-B-type natriuretic peptide levels in critically ill children with sepsis versus acute left ventricular dysfunction. Pediatrics 118(4):e1165–e1168 Johns MC, Stephenson C (2008) Amino-terminal pro-B-type natriuretic peptide testing in neonatal and pediatric patients. Am J Cardiol 101(S):76A–81A Soldin SJ, Soldin OP, Boyajian AJ, Taskier MS (2006) Pediatric brain natriuretic peptide and N-terminal pro-brain natriuretic peptide reference intervals. Clinica Chimica Acta 366:304–308 Nir A, Lindinger A, Rauh M, Bar-Oz B, Laer S, Schwachtgen L, Koch A, Falkenberg J, Mir TS (2009) NT-pro-B-type natriuretic peptide in infants and children: reference values based on combined data from four studies. Pediatr Cardiol 30:3–8 Baggish AL, van Kimmenade RRJ, Januzzi JL (2008) The differential diagnosis of an elevated amino-terminal pro-B-type natriuretic peptide level. Am J Cardiol 101(suppl):43A–48A Farombi-Oghuvbu I, Matthews T, Mayne PD, Guerin H, Corcoran JD (2008) N-terminal pro-B-type natriuretic peptide: a measure of significant patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed 93:F257–F260 Nuntnarumit P, Khositseth A, Thanomsingh P (2009) N-terminal probrain natriuretic peptide and patent ductus arteriosus in preterm infants. J Perinatol 29:137–142 Kawamura T, Wago M, Kawaguoni H, Tahara M, Yuge M (2000) Plasma brain natriuretic peptide concentrations in patients with Kawasaki disease. Pediatr Int 42:241–248 Das BB, Raj S, Solinger R (2009) Natriuretic peptides in cardiovascular diseases of fetus, infants and children. Cardiovasc Hem Agents Med Chem 7:43–51 Dahdah N, Siles A, Fournier A, Cousineau J, Delvin E, Saint-Cyr C, Spiegelblatt L, Bommy Y, Vartian M, Montigny M (2009) Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki disease. Pediatr Cardiol 30:810–817 Tasklesen M, Taskesen T, Katar S, Karadede A, Ali Tas M (2009) Elevated Plasma levels of N-terminal pro-brain natriuretic peptide in children with acute poststreptococcal glomerulonephritis. Tohoku J Exp Med 217:295–298 Tissieres P, Aggoun Y, Da Cruz E, Sierra J, Mensi N, Kalangos A, Beghetti M (2006) Comparison of classifications for heart failure in children undergoing valvular surgery. J Pediatrics 149(2):210–215 Ucar T, Ileri T, Uysal Z, Atalays S, Tutar E. Early detection of myocardial dysfunction in childhood patients with beta-thalassaemia major. In: 42nd Annual meeting of the AEPC 2007, Poster 90 Isma’eel H, Chafic AH, Rassi FE, Inati A, Koussa, Daher R, Gharzuddin W, Alam S, Taher A (2008) Relation between iron-overload indices, cardiac echo-doppler and biochemical markers in thalassemia intermedia. Am J Cardiol 102(3):363–367 Mokhtar GM, Adly AAM, El Alfy MS, Tawfik LM, Khairy AT (2010) N-terminal natriuretic peptide and ventilation-perfusion lung scan in sickle cell disease and thalassemia patients with pulmonary hypertension. Hemoglobin 34(1):78–94 Van Bockel EAP, Lind JS, Zijlstra JG, Wijkstra PJ, Meijer PM, Van den Berg MP, Slart RHJA, Aarts LPHJ, Tulleken JE (2009) Cardiac assessment of patients with late stage Duchenne muscular dystrophy. Netherlands heart J 17(6):232–237 Soker M, Kervancioglu M (2005) Plasma concentrations of NT-proBNP and cardiac troponin I in relation to doxyrubicin-induced cardiomyopathy and cardiac function in childhood malignancy. Saudi Med J 26(8):1197–1202 Germanakis I, Kalmanti M, Parthenakis F, Nikitovic D, Stiakaki E, Patrianakos A, Vardas PE (2006) Correlation of plasma N-terminal pro-brain natriuretic peptide levels with left ventricle mass in children treated with anthracyclines. Int J Cardiol 108(2):212–215 Favilli S, Frenos S, Lasigni D, Frenos F, Pollini I, Bernini G, Arico M, Roberta M (2009) The use of B-type natriuretic peptide in paediatric patients: a review of literature. J Cardio-vasc Med 10(4):298–302 Reynolds EW, Ellington JG, Vranilav M, Bada HS (2004) BNP in the diagnosis and management of PHT of the newborn. Pediatrics 114(5):1297–1304 Van Albada ME, Loot FG, Fokkema R, Roofthooft MTR, Berger R MF (2008) Biological serum markers in the management of pediatric pulmonary arterial hypertension. Pediatr Res 63:321–327 Ben Tov A, Paret G, Sela BA, Blau H, Hegesh J, Efrati O, Yahav Y, Augarten A (2007) N-terminal pro B-type natriuretic peptide (N-BNP) in cystic fibrosis patients. Pediatr Pulmonol 42(8):699–703 El-Khuffash A, Amoruso M, Culliton M, Molloy E (2007) NT pro BNP a marker of ductal hemodynamic significance in preterm infants: a prospective observational study. Arch Dis Child Fetal Neonatal Ed 92:421–422 El-Khuffash A, Molloy EJ (2006) Are B-type natriuretic peptide (BNP) and N-terminal-pro-BNP useful in neonates? Arch Dis Child Fetal Neonatal Ed 92:F320–F324 Ramakrishnan S, Heung YM, Round J, Morris TP, Collinson P, Williams AF (2009) Early N-terminal pro-brain natriuretic peptide measurements predict clinically significant ductus arteriosus in preterm infants. Acta Paediatr 98:1254–1259 Holmstroem H, Hall C, Thaulow E (2001) Plasma levels of natriuretic peptides and hemodynamic assessment of patent ductus arteriosus in preterm infants. Acta Paediatr 90:84–191 Cohen S, Springer C, Avital A, Perles Z, Rein AJ, Argaman Z, Nir A (2005) Amino-terminal pro-brain-type natriuretic peptide: heart or lung disease in pediatric respiratory distress? Pediatrics 115(5):1347–1350 Maher KO, Reed H, Cuadrado A, Simsic J, Mahle WT, DeGuzman M, Lerong T, Bandyopadhyay S (2008) B-type natriuretic peptide in the emergency diagnosis of critical heart disease in children. Pediatrics 121:e1484–e1488 Koulouri S, Acherman RJ, Wong PC, Chan LS, Lewis AB (2004) Utility of B type natriuretic peptide in differentiating congestive heart failure from lung disease in pediatric patients with respiratory distress. Pediatr Cardiol 25:341–346